Immune-related toxicities in NSCLC: Real-world experience from a tertiary cancer center

被引:0
|
作者
d'Arienzo, P. D. [1 ]
Olsson-Brown, A. C. [2 ]
Sallam, M. [3 ]
Ortega-Franco, A. [2 ]
Wong, H. [2 ]
Escriu, C. [2 ]
机构
[1] Royal Liverpool Univ Hosp, Gen Internal Med, Liverpool, Merseyside, England
[2] Clatterbridge Canc Ctr, NHS Fdn Trust, Med Oncol Dept, Wirral, Merseyside, England
[3] Univ Liverpool, Med Sch, Liverpool, Merseyside, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
75P
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Immune-Related Adverse Events Associated with Atezolizumab: Insights from Real-World Pharmacovigilance Data
    Frey, Connor
    Etminan, Mahyar
    ANTIBODIES, 2024, 13 (03)
  • [22] Real-world experience of immune checkpoint inhibitors in MSI-H/dMMR metastatic colorectal cancer in a tertiary cancer center in Saudi Arabia
    Ajina, R.
    Alhareeri, A.
    Philip, W.
    Alsekait, N.
    Alarifi, N.
    Alismail, H.
    Alshieban, S.
    Almuzzaini, B.
    Alshammari, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S117 - S117
  • [23] Management of immune-related adverse events: A single-center retrospective analysis in a real-world scenario.
    Iacono, Donatella
    Vitale, Maria Grazia
    Cortiula, Francesco
    Macerelli, Marianna
    Cinausero, Marika
    Minisini, Alessandro Marco
    Valent, Francesca
    Tullio, Annarita
    Palmero, Lorenza
    Targato, Giada
    Zara, Diego
    Fasola, Gianpiero
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Ophthalmic Immune-Related Adverse Events and Association with Survival: Results From a Real-World Database
    Quiruz, Lee
    Yavari, Negin
    Kikani, Bijal
    Gupta, Ankur Sudhir
    Wai, Karen Michelle
    Kossler, Andrea Lora
    Ludwig, Chase
    Koo, Eubee Baughn
    Rahimy, Ehsan
    Mruthyunjaya, Prithvi
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 268 : 348 - 359
  • [25] The Prevalence and Patterns of Toxicity With Immune Checkpoint Inhibitors in Solid Tumors: A Real-World Experience From a Tertiary Care Center in Oman
    Salman, Bushra
    Alward, Nameer M.
    Al-Hashami, Zamzam
    Al-Sharqi, Hadil
    Al -Sayegh, Hasan
    Burney, Ikram A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [26] Doctor reported outcomes: Real-world data from a tertiary eye cancer center
    Maheshwari, Abhilasha
    Finger, Paul T.
    Malpani, Abhishek
    Jain, Puneet
    Tomar, Ankit Singh
    Garg, Gaurav
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (01) : 135 - 139
  • [27] Real-World Adherence to Toxicity Management Guidelines for Immune-Related Adverse Events
    Teimouri, Arezou
    Minard, Laura, V
    Scott, Samantha N.
    Daniels, Amanda
    Snow, Stephanie
    CURRENT ONCOLOGY, 2022, 29 (05) : 3104 - 3117
  • [28] Acknowledging and addressing real-world challenges to treating immune-related adverse events
    von Itzstein, Mitchell S.
    Gerber, David E.
    Bermas, Bonnie L.
    Meara, Alexa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (07)
  • [29] Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: observations from a tertiary care center
    Desai, M.
    Hajj-Ali, A.
    Rutkowski, K.
    Ospina, S.
    Gaballa, A.
    Emery, M.
    Asher, C.
    Xu, B.
    Thamilarasan, M.
    Popovic, Z.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [30] Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: Observations from a tertiary care center
    Desai, Milind Y.
    Hajj-Ali, Adel
    Rutkowski, Katy
    Ospina, Susan
    Gaballa, Andrew
    Emery, Michael
    Asher, Craig
    Xu, Bo
    Thamilarasan, Maran
    Popovic, Zoran B.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2024, 86 : 62 - 68